Home › Funds › Renaissance Technologies › RNXT
Renaissance Technologies position in RNXT
RENOVORX INC · Health Care
Latest position (Q2 2026)11.40K sh
Reported value held$11.17K
Portfolio Weight0.00%
First reportedQ2 2024
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2024 | 10.00K | $11.30K | New |
| Q4 2024 | 64.90K | $83.72K | New |
| Q1 2025 | 27.66K | $27.38K | Reduce |
| Q1 2025 | 27.66K | $27.38K | Reduce |
| Q2 2025 | 251.80K | $331.12K | Add |
| Q2 2025 | 251.80K | $331.12K | Add |
| Q3 2025 | 313.55K | $398.21K | Add |
| Q4 2025 | 117.46K | $98.68K | Reduce |
| Q1 2026 | 13.00K | $13.13K | Reduce |
| Q2 2026 | 11.40K | $11.17K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding RNXT
- Vanguard Group 1.61M sh · $1.35M · Q4 2025
- Geode Capital Management 424.15K sh · $415.69K · Q2 2026
- Citadel Advisors 133.60K sh · $130.93K · Q2 2026
- Northern Trust Corp 85.21K sh · $83.50K · Q2 2026
- UBS Group AG 20.82K sh · $20.40K · Q2 2026
- Morgan Stanley 7.10K sh · $6.96K · Q2 2026